2.18
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ACHV Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.42
Aprire:
$2.34
Volume 24 ore:
579.90K
Relative Volume:
2.50
Capitalizzazione di mercato:
$82.83M
Reddito:
-
Utile/perdita netta:
$-32.94M
Rapporto P/E:
-1.964
EPS:
-1.11
Flusso di cassa netto:
$-24.95M
1 W Prestazione:
-21.58%
1M Prestazione:
-25.09%
6M Prestazione:
-56.57%
1 anno Prestazione:
-51.34%
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Nome
Achieve Life Sciences Inc
Settore
Industria
Telefono
425-686-1500
Indirizzo
22722 29TH DR. SE, SEATTLE, BC
Confronta ACHV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ACHV
Achieve Life Sciences Inc
|
2.18 | 82.83M | 0 | -32.94M | -24.95M | -1.11 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
555.11 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
238.51 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
2024-09-27 | Iniziato | Raymond James | Strong Buy |
2023-05-10 | Reiterato | Maxim Group | Buy |
2021-06-23 | Iniziato | Oppenheimer | Outperform |
Achieve Life Sciences Inc Borsa (ACHV) Ultime notizie
ACHV Stock Touches 52-Week Low at $2.5 Amid Market Challenges - Investing.com UK
ACHIEVE LIFE SCIENCES INC- The GF Score's 5 Key Aspects of Analysis - GuruFocus
Contrasting Achieve Life Sciences (NASDAQ:ACHV) & Oruka Therapeutics (NASDAQ:ORKA) - Defense World
Achieve Life Sciences, Inc. (NASDAQ:ACHV) CFO Purchases $28,900.00 in Stock - MarketBeat
Insider Buying: Mark Oki Acquires Shares of Achieve Life Sciences Inc (ACHV) - GuruFocus
Achieve Life Sciences, Inc. (ACHV): A Bull Case Theory - MSN
Achieve Life Sciences CEO Richard Stewart purchases $28,598 in stock - Investing.com India
Achieve Life Sciences CFO Mark Oki buys $28,887 in stock - Investing.com India
Achieve Life Sciences (ACHV) Expected to Announce Quarterly Earnings on Thursday - Defense World
Achieve Life Sciences Executives Acquire Shares - TradingView
Achieve Life Sciences CFO Mark Oki buys $28,887 in stock By Investing.com - Investing.com UK
Achieve Life Sciences CEO Richard Stewart purchases $28,598 in stock By Investing.com - Investing.com UK
Achieve Life Sciences: Promising Clinical Progress and Strategic Leadership Enhancements Justify Buy Rating - TipRanks
ACHV stock touches 52-week low at $2.81 amid market challenges - Investing.com India
Achieve Life Sciences (NASDAQ:ACHV) Announces Earnings Results - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2024 Earnings Call Transcript - Insider Monkey
ACHV: 2Q:25 NDA Submission - Yahoo Finance
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo
Achieve Life Sciences Reports 2024 Financial Results - TipRanks
Achieve Life Sciences misses Q4 earnings, shares fall By Investing.com - Investing.com South Africa
Achieve Life Sciences misses Q4 earnings, shares fall - Investing.com
Earnings call transcript: Achieve Life Sciences Q4 2024 sees slight EPS miss By Investing.com - Investing.com South Africa
Earnings call transcript: Achieve Life Sciences Q4 2024 sees slight EPS miss - Investing.com
Achieve Life Sciences Q4 Loss Widens - Nasdaq
Achieve Life Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program - The Manila Times
ACHIEVE LIFE SCIENCES Earnings Results: $ACHV Reports Quarterly Earnings - Nasdaq
ACHIEVE LIFE SCIENCES, INC. SEC 10-K Report - TradingView
Achieve Life Sciences Announces Planned NDA Submission for Cytisinicline Targeting End of Q2 2025 - Nasdaq
Achieve Life Sciences Reports Financial Results for Fourth - GlobeNewswire
Achieve Life Sciences Hits Major FDA Milestone as Q4 Results Show $34.4M Cash Position - StockTitan
Earnings Scheduled For March 11, 2025 - Benzinga
SBI Securities Co. Ltd. Purchases New Shares in Achieve Life Sciences, Inc. (NASDAQ:ACHV) - Defense World
Achieve Life Sciences (ACHV) Projected to Post Earnings on Tuesday - Defense World
Can This Smoking Cessation Drug Developer Disrupt a $20B Market? Key Presentation Coming - StockTitan
Achieve Life Sciences to Present at the Barclays 27th Annual Global Healthcare Conference - The Manila Times
Achieve Life Sciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call and Webcast on March 11, 2025 - The Manila Times
INVESTVIEW, INC. ANNOUNCES LAUNCH OF STOCK REPURCHASE PROGRAM - The Manila Times
Achieve Life Sciences to Report Fourth Quarter and Year-End 2024 Financial Results and Cytisinicline Development Update - Nasdaq
Achieve Life Sciences to Announce Fourth Quarter and - GlobeNewswire
ACHV Stock Touches 52-Week Low at $2.83 Amid Market Challenges - Investing.com Australia
Qualia Supplements Achieve Multiple Finalist Honors For Product Excellence At 2025 NEXTY Awards - Yahoo Finance
ACHV Stock Touches 52-Week Low at $2.83 Amid Market Challenges By Investing.com - Investing.com South Africa
Achieve Life Sciences, Inc. to Host Earnings Call - ACCESS Newswire
Achieve Life Sciences to Participate in Two Upcoming Investor Conferences - ACCESS Newswire
Veradigm Becomes First EHR Media Platform to Achieve POCMA Certification - Business Wire
CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules - ACCESS Newswire
Technology | Definition, Examples, Types, & Facts - Britannica
Artificial Intelligence (AI) in Life Sciences Market Size to Worth USD 13.89 Bn by 2034 - BioSpace
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV) - Insider Monkey
Achieve Life Sciences Inc Azioni (ACHV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Achieve Life Sciences Inc Azioni (ACHV) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Stewart Richard Alistair | Chieve Executive Officer |
Mar 17 '25 |
Buy |
2.86 |
10,000 |
28,598 |
60,876 |
Wan Jerry | Principal Accounting Officer |
Apr 19 '24 |
Option Exercise |
0.00 |
5,625 |
0 |
12,057 |
JACOBS CINDY | President & CMO |
Apr 19 '24 |
Option Exercise |
0.00 |
16,250 |
0 |
34,511 |
Stewart Richard Alistair | Executive Chairman |
Apr 19 '24 |
Option Exercise |
0.00 |
22,500 |
0 |
61,001 |
Bencich John | CEO |
Apr 19 '24 |
Option Exercise |
0.00 |
25,000 |
0 |
101,724 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):